Log In
Print this Print this

SetoFilm (ondansetron RapidFilm) (BA-030)

  Manage Alerts
Collapse Summary General Information
Company Applied Pharma Research S.A.
DescriptionDissolving oral film strip formulation of ondansetron using RapidFilm technology
Molecular Target Serotonin (5-HT3) receptor
Mechanism of ActionSerotonin (5-HT3) receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationEmesis
Indication DetailsPrevent chemotherapy- and radiation-induced nausea and vomiting; Treat post-operative nausea and vomiting (PONV)
Regulatory Designation
PartnerNorgine B.V.;
SciClone Pharmaceuticals Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today